Marshall Wace’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.9M | Sell |
44,059
-18,983
| -30% | -$9.56M | 0.02% | 691 |
|
|
2025
Q4 | $29.4M | Sell |
63,042
-1,675
| -3% | -$778K | 0.03% | 503 |
|
|
2025
Q3 | $27.6M | Buy |
64,717
+61,217
| +1,749% | +$23.7M | 0.03% | 523 |
|
|
2025
Q2 | $1.34M | Sell |
3,500
-1,300
| -27% | -$468K | ﹤0.01% | 1732 |
|
|
2025
Q1 | $1.66M | Buy |
+4,800
| New | +$1.54M | ﹤0.01% | 1548 |
|
|
2024
Q4 | – | Sell |
-3,500
| Closed | -$1.42M | – | 2751 |
|
|
2024
Q3 | $1.42M | Buy |
3,500
+1,900
| +119% | +$696K | ﹤0.01% | 1506 |
|
|
2024
Q2 | $514K | Buy |
+1,600
| New | +$520K | ﹤0.01% | 1950 |
|
|
2023
Q4 | – | Sell |
-1,174
| Closed | -$290K | – | 2343 |
|
|
2023
Q3 | $289K | Buy |
+1,174
| New | +$321K | ﹤0.01% | 1898 |
|
|
2023
Q2 | – | Sell |
-6,611
| Closed | -$1.74M | – | 2652 |
|
|
2023
Q1 | $1.74M | Sell |
6,611
-13,504
| -67% | -$3.43M | ﹤0.01% | 1524 |
|
|
2022
Q4 | $4.83M | Sell |
20,115
-176,076
| -90% | -$39.4M | 0.01% | 1208 |
|
|
2022
Q3 | $36.1M | Buy |
196,191
+147,352
| +302% | +$29.4M | 0.08% | 286 |
|
|
2022
Q2 | $8.21M | Buy |
48,839
+15,986
| +49% | +$3.43M | 0.02% | 1011 |
|
|
2022
Q1 | $8.23M | Sell |
32,853
-85,735
| -72% | -$21.5M | 0.02% | 1020 |
|
|
2021
Q4 | $30.5M | Buy |
+118,588
| New | +$29M | 0.06% | 347 |
|
|
2021
Q1 | – | Sell |
-61,909
| Closed | -$10.2M | – | 2628 |
|
|
2020
Q4 | $10.2M | Buy |
61,909
+49,349
| +393% | +$7.22M | 0.06% | 343 |
|
|
2020
Q3 | $1.57M | Sell |
12,560
-356,099
| -97% | -$44.1M | 0.01% | 874 |
|
|
2020
Q2 | $35.8M | Buy |
368,659
+205,365
| +126% | +$21.3M | 0.25% | 87 |
|
|
2020
Q1 | $14.7M | Sell |
163,294
-188,402
| -54% | -$24.4M | 0.15% | 152 |
|
|
2019
Q4 | $52M | Buy |
351,696
+33,248
| +10% | +$4.46M | 0.36% | 54 |
|
|
2019
Q3 | $38.3M | Buy |
318,448
+312,614
| +5,358% | +$40.4M | 0.3% | 68 |
|
|
2019
Q2 | $789K | Buy |
+5,834
| New | +$738K | 0.01% | 985 |
|
|
2019
Q1 | – | Sell |
-3,704
| Closed | -$461K | – | 1853 |
|
|
2018
Q4 | $461K | Sell |
3,704
-21,596
| -85% | -$2.9M | ﹤0.01% | 1131 |
|
|
2018
Q3 | $3.52M | Buy |
+25,300
| New | +$3.15M | 0.03% | 543 |
|
|
2016
Q3 | – | Sell |
-5,014
| Closed | -$386K | – | 1018 |
|
|
2016
Q2 | $386K | Buy |
+5,014
| New | +$396K | ﹤0.01% | 868 |
|
|
2015
Q3 | – | Sell |
-15,768
| Closed | -$1.43M | – | 983 |
|
|
2015
Q2 | $1.43M | Buy |
+15,768
| New | +$1.26M | 0.02% | 535 |
|
|
2015
Q1 | – | Sell |
-57,134
| Closed | -$4.19M | – | 853 |
|
|
2014
Q4 | $4.19M | Sell |
57,134
-148,063
| -72% | -$10.4M | 0.06% | 337 |
|
|
2014
Q3 | $14.5M | Buy |
205,197
+190,354
| +1,282% | +$12.6M | 0.21% | 138 |
|
|
2014
Q2 | $837K | Buy |
+14,843
| New | +$783K | 0.01% | 533 |
|
Other funds holding HCA
VCM
VPM
Marshall Wace's HCA Position: Q1 2026 in Review
Marshall Wace reduced its HCA Healthcare (HCA) stake by 30% in Q1 2026, selling an estimated $9.56M and leaving 44,059 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #691.
Marshall Wace first reported a position in HCA in Q2 2014 and has held it in 28 quarters since. The position peaked at $52M in Q4 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Marshall Wace held 44,059 shares of HCA Healthcare worth $20.9M as of Q1 2026.
- Marshall Wace sold 18,983 HCA Healthcare shares in Q1 2026, an estimated $9.56M.
- HCA Healthcare made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #691 holding.
- Marshall Wace first reported a position in HCA Healthcare in Q2 2014 and has held it in 28 quarters since.
- Marshall Wace's HCA Healthcare position peaked at $52M in Q4 2019.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.